摘要
Objective To investigate the role of oxidative stress in itch-indicative scratching behavior in mice, and further- more, to define the cellular and molecular mechanisms underlying oxidative stress-mediated itch. Methods Scratching behavior was induced by intradermal injection of the oxidants hydrogen peroxide （H202） or tert-butylhydroperoxide （tBHP） into the nape of the neck in mice. The mice were observed for 30 rain. Results Intradermal H202 （0.03%-1%） or tBHP （1-30 pmol） elicited robust scratching behavior, displaying an inverted U-shaped dose-response curve. Naloxone, an opioid receptor antagonist, but not morphine, largely suppressed the oxidant-induced scratching. Chlorpheniramine, a histamine H1 receptor antagonist, blocked histamine- but not oxidant-induced scratching, indicating the involvement of a histamine-independent mechanism in oxidant-evoked itch. Further, resiniferatoxin treatment abolished oxidant-induced scratching, suggesting an essential role of C-fibers. Notably, blockade of transient receptor potential subtype ankyrin 1 （TRPA1） with the selective TRPA1 antagonist HC-030031, or genetic deletion of Trpal but not Trpvl （subfamily V, mem- ber 1） resulted in a profound reduction in H202-evoked scratching. Finally, systemic administration of the antioxidant N- acetyl-L-cysteine or trolox （a water-soluble vitamin E analog） attenuated scratching induced by the oxidants. Conclusion Oxidative stress by different oxidants induces profound scratching behavior, which is largely histamine- and TRPV1- independent but TRPAl-dependent. Antioxidants and TRPA1 antagonists may be used to treat human itch conditions as- sociated with oxidative stress.
Objective To investigate the role of oxidative stress in itch-indicative scratching behavior in mice, and further- more, to define the cellular and molecular mechanisms underlying oxidative stress-mediated itch. Methods Scratching behavior was induced by intradermal injection of the oxidants hydrogen peroxide （H202） or tert-butylhydroperoxide （tBHP） into the nape of the neck in mice. The mice were observed for 30 rain. Results Intradermal H202 （0.03%-1%） or tBHP （1-30 pmol） elicited robust scratching behavior, displaying an inverted U-shaped dose-response curve. Naloxone, an opioid receptor antagonist, but not morphine, largely suppressed the oxidant-induced scratching. Chlorpheniramine, a histamine H1 receptor antagonist, blocked histamine- but not oxidant-induced scratching, indicating the involvement of a histamine-independent mechanism in oxidant-evoked itch. Further, resiniferatoxin treatment abolished oxidant-induced scratching, suggesting an essential role of C-fibers. Notably, blockade of transient receptor potential subtype ankyrin 1 （TRPA1） with the selective TRPA1 antagonist HC-030031, or genetic deletion of Trpal but not Trpvl （subfamily V, mem- ber 1） resulted in a profound reduction in H202-evoked scratching. Finally, systemic administration of the antioxidant N- acetyl-L-cysteine or trolox （a water-soluble vitamin E analog） attenuated scratching induced by the oxidants. Conclusion Oxidative stress by different oxidants induces profound scratching behavior, which is largely histamine- and TRPV1- independent but TRPAl-dependent. Antioxidants and TRPA1 antagonists may be used to treat human itch conditions as- sociated with oxidative stress.
基金
supported by grants from the US National Institutes of Health (R01-DE17794,R01-NS54362 and R01-NS67686)
